These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 37537230)
1. Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography. Agyekum EA; Wang YG; Xu FJ; Akortia D; Ren YZ; Chambers KH; Wang X; Taupa JO; Qian XQ Sci Rep; 2023 Aug; 13(1):12604. PubMed ID: 37537230 [TBL] [Abstract][Full Text] [Related]
2. Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAF Wang YG; Xu FJ; Agyekum EA; Xiang H; Wang YD; Zhang J; Sun H; Zhang GL; Bo XS; Lv WZ; Wang X; Hu SD; Qian XQ Front Endocrinol (Lausanne); 2022; 13():872153. PubMed ID: 35527993 [TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAF Wang X; Xu F; Gao J; Agyekum EA; Sun H; Zhang G; Li X; Xiang H; Hu S; Qian X J Clin Ultrasound; 2022 Sep; 50(7):942-950. PubMed ID: 35779272 [TBL] [Abstract][Full Text] [Related]
4. Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Chen H; Zhu L; Zhuang Y; Ye X; Chen F; Zeng J Cancer Control; 2024; 31():10732748241295347. PubMed ID: 39425895 [TBL] [Abstract][Full Text] [Related]
5. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma. Paek SH; Kim BS; Kang KH; Kim HS World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392 [TBL] [Abstract][Full Text] [Related]
6. BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates. Al-Salam S; Sharma C; Afandi B; Al Dahmani K; Al-Zahrani AS; Al Shamsi A; Al Kaabi J PLoS One; 2020; 15(4):e0231341. PubMed ID: 32315324 [TBL] [Abstract][Full Text] [Related]
7. Targeting Diagnosis of High-Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAF Xie F; Yan L; Li YM; Lan Y; Xiao J; Zhang MB; Jin Z; Zhang Y; Tian XQ; Zhu YQ; Li ZP; Luo YK J Ultrasound Med; 2022 Nov; 41(11):2789-2802. PubMed ID: 35229905 [TBL] [Abstract][Full Text] [Related]
9. BRAF Shi C; Cao J; Shi T; Liang M; Ding C; Lv Y; Zhang W; Li C; Gao W; Wu G; Man J World J Surg Oncol; 2020 Jun; 18(1):145. PubMed ID: 32593310 [TBL] [Abstract][Full Text] [Related]
10. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation. Chen H; Pan WK; Ren SY; Zhou YL Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891 [TBL] [Abstract][Full Text] [Related]
11. Risk and Prognostic Factors for BRAF Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194 [TBL] [Abstract][Full Text] [Related]
12. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules. Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402 [TBL] [Abstract][Full Text] [Related]
14. Associations of BRAF Tan Y; Zhong J; Zheng T; Fu Y; Liu M; Wang G Pediatr Radiol; 2024 Jun; 54(7):1128-1136. PubMed ID: 38771344 [TBL] [Abstract][Full Text] [Related]
15. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011 [TBL] [Abstract][Full Text] [Related]
16. Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. Pupilli C; Pinzani P; Salvianti F; Fibbi B; Rossi M; Petrone L; Perigli G; De Feo ML; Vezzosi V; Pazzagli M; Orlando C; Forti G J Clin Endocrinol Metab; 2013 Aug; 98(8):3359-65. PubMed ID: 23788690 [TBL] [Abstract][Full Text] [Related]
17. Associations of the BRAF V600E Mutation and PAQR3 Protein Expression with Papillary Thyroid Carcinoma Clinicopathological Features. Gao J; Ma XP; Deng FS; Jiang L; Jia WD; Li M Pathol Oncol Res; 2020 Jul; 26(3):1833-1841. PubMed ID: 31758408 [TBL] [Abstract][Full Text] [Related]
18. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study. Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008 [TBL] [Abstract][Full Text] [Related]
19. Clinical Analysis of BRAF Dong SY; Chen J; Xia EJ; Lin RX; Du HY; Wang OC; Zhang XH; Hao RT Am Surg; 2020 May; 86(5):450-457. PubMed ID: 32684022 [TBL] [Abstract][Full Text] [Related]
20. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer. Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]